Labs / ADME, DMPK & toxicology

Authera
Oslo, Norway · authera.bio
On your own
Free. Their own form.
Through Midgard
Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.
Authera is a pre-clinical biotechnology company focused on developing novel therapeutic biologics. It was founded in 2022 as a spin-off from Oslo University Hospital and the University of Oslo and is based in Oslo, Norway. The company works on albumin- and antibody-based molecules, with a focus on FcRn biology and exudative eye diseases.
They take quote requests by email.
What they offer
Molecular design
Designs novel therapeutic biologics with tailored FcRn binding and transport properties.
Protein engineering studies
Conducts comprehensive studies of protein engineering strategies for albumin- and antibody-based molecules.
Advanced biochemical assays
Uses biochemical assays to study how therapeutic candidates engage FcRn.
Cellular assays
Uses cellular assays to evaluate intracellular sorting and transport of candidate molecules.
In vivo mouse model studies
Uses mouse models to assess pharmacokinetic profiles of novel therapeutic candidates.
What they work on
- Modalities
- Antibody
- Species and models
- mouse
- Assays and studies
- biochemical assays, cellular assays
- Therapeutic areas
- exudative eye diseases
- Sites
- Oslo, Norway
- Founded
- 2022
Similar labs. Altogen Labs, Bioneeds, Liveon Biolabs, Manhattan BioSolutions
Found in a contract services directory. Listing built from authera.bio. Work here? Claim this listing.